Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state
scientific article published on 01 January 2002
.jpg/500px-Acute_Myeloid_Leukemia_(M2_type).jpg)